Dr Ik Shin Chin: 'Bispecific antibodies and antibody-drug conjugates in head and neck cancer'
7:00pm - 8:00pm /
Thursday 15th January 2026
/ Online event
Type: Lecture /
Category: Research
- Debbie Horne, Liverpool Head and Neck Centre Manager
- Admission: Free. Registration not required.
- Online location
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
LIVERPOOL HEAD AND NECK CENTRE SEMINAR SERIES: RESEARCH EDUCATION DEVELOPMENT LECTURES 2026 Dr Ik Shin Chin has joined the Department of Molecular and Clinical Cancer Medicine as a Clinical Senior Lecturer and Honorary Consultant in Medical Oncology in early phase trials at the Clatterbridge Cancer Centre.
She underwent her medical oncology training in the West Midlands. She received funding to pursue her PhD under the Cancer Research UK Clinical PhD Fellowship with the University of Birmingham in 2019.
Dr Chin pursued an Advanced Immune and Cell therapy fellowship at the Christie’s Hospital, Manchester and worked within their ECMT team in the delivery of early phase trials
She underwent her medical oncology training in the West Midlands. She received funding to pursue her PhD under the Cancer Research UK Clinical PhD Fellowship with the University of Birmingham in 2019.
Dr Chin pursued an Advanced Immune and Cell therapy fellowship at the Christie’s Hospital, Manchester and worked within their ECMT team in the delivery of early phase trials